Informed consent on heparin-induced thrombocytopenia during thrombosis prophylaxis. A pilot study including 460 patients;Aufklärung über die Heparin-induzierte Thrombozytopenie im Rahmen der Thromboseprophylaxe mit Heparin: Pilot-Studie bei 460 unfallchirurgischen Patienten

Deutsche Medizinische Wochenschrift

Volumn 128, Issue 42, 2003, Pages 2184-2188

  Hinz, P ^a   Lubenow, N ^a   Ekkernkamp, A ^a   Greinacher, A ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ARTICLE; COMPREHENSION; CONTROLLED STUDY; DECISION MAKING; DISEASE ASSOCIATION; DRUG CHOICE; DRUG EFFECT; DRUG INDICATION; EVALUATION; FEASIBILITY STUDY; FEMALE; FOLLOW UP; GERMANY; HEALTH CARE QUALITY; HEPARINIZATION; HUMAN; INCIDENCE; INFORMED CONSENT; INJURY; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT INFORMATION; PILOT STUDY; PLASTIC SURGERY; QUESTIONNAIRE; RISK; SIDE EFFECT; STATISTICAL ANALYSIS; THROMBOCYTOPENIA; THROMBOSIS; THROMBOSIS PREVENTION; TREATMENT OUTCOME;

ADULT; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INFORMED CONSENT; PILOT PROJECTS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RECONSTRUCTIVE SURGICAL PROCEDURES; RISK ASSESSMENT; THROMBOCYTOPENIA; THROMBOSIS; WOUNDS AND INJURIES;

EID: 0142257899     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-42985     Document Type: Article

References (18)

1. Bircher AJ, Czendlik CH, Messmer SL, Muller P, Howald H. Acute urticaria caused by subcutaneous recombinant hirudin: evidence for an IgG-mediated hypersensitivity reaction. J Allergy Clin Immunol 1996; 98: 994-996
2. Bundesgerichtshof 2000; JZ: 901.
3. Eichler P, Friesen HJ, Lubenow N, Jaeger B, Greinacher A. Antihirudin antibodies in patients with heparin-induced thrombocytopenia treated with lepirudin: incidence, effects on aPTT, and clinical relevance. Blood 2000; 96: 2373-2378
4. EMEA, Public Statement on REFLUDAN (INN: Lepirudin), 29 October 2002, Doc. Ref: EMEA/27717/02.
5. Eriksson BI, Wille-Jörgensen P, Kälebo P et al. A comparison of recombinant hirudin with a low-molecular weight heparin to prevent thromboembolic complications after total hip replacement. N Engl J Med 1997; 337: 1329-3135
6. Eriksson BI, Ekman S, Lindbratt S et al. Prevention of thromboembolism with use of recombinant hirudin. Results of a double-blind, multicenter trial comparing the efficacy of desirudin (Revasc) with that of unfractionated heparin in patients having a total hip replacement. J Bone Joint Surg Am 1997; 79: 326-333
7. Greinacher A, Potzsch B, Amiral J, Dummel V, Eichner A, Mueller-Eckhardt C. Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen. Thromb Haemost 1994; 71: 247-251
8. Greinacher A, Eichler P, Albrecht D, Strobel U, Poetzsch B, Eriksson BI. Anti-hirudin antibodies following low-dose subcutaneous treatment with desirudin for thrombosis prophylaxis after hip-replacement surgery: incidence and clinical relevance. Blood 2003; 101: 2617-2619
9. Greinacher A, Lubenow N. Recombinant hirudin in clinical practice: focus on lepirudin. Circulation 2001; 103: 1479-1484
10. Greinacher A, Eichler P, Lubenow N. Anaphylactic reactions associated with lepirudin in patients with heparin-induced thrombocytopenia (HIT). Annals of Hematology 2003; 82: S30(suppl 1)
11. Lee DH, Warkentin TE. Frequency of heparin-induced thrombocytopenia. 2. Auflage, New York, Marcel Dekker, In: Warkentin TE, Greinacher A (eds). Heparin-induced thrombocytopenia. 2001: 87-122
12. Oberlandesgericht Düsseldorf Versicherungsrecht, 1999; 49: 1371
13. Song X, Huhle G, Wang L, Hoffmann U, Harenberg J. Generation of anti-hirudin antibodies in heparin-induced thrombocytopenic patients treated with r-hirudin. Circulation 1999; 100: 1528-1532
14. Ulsenheimer K. Rechtliche Aspekte bei der Prophylaxe und Therapie der venösen Thrombose. Chirurg 2001; 40: 104-110
15. Warkentin TE, Kelton JE. A 14-year study of heparin-induced thrombocytopenia. Am J Med 1996; 101: 502-507
16. Warkentin TE, Kelton JG. Temporal aspects of heparin-induced thrombocytopenia. N Eng J Med 2001; 344: 1286-1292
17. Warkentin TE. Clinical picture of heparin-induced thrombocytopenia. 2. Auflage, New York, Marcel Dekker, In: Warkentin TE, Greinacher A (eds). Heparin-induced thrombocytopenia. 2001: 43-86
18. Weismann RE, Tobin RW. Arterial embolism occurring during systemic heparin therapy. Arch Surg 1958; 76: 219-227